سعر يوريبان Uripan‏ 0.1% شراب 120 مل 2026

Oxybutynin 0.1% (120 ml) syrup (adwia).

• Anticholinergic effects such as dry mouth, constipation, blurred vision, somnolence and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Urinary retention, gastric retention and other severe decreased GI motility conditions, uncontrolled narrow-angle glaucoma (and patients at risk of these); hypersensitivity to oxybutynin or components.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Angioedema of face, lips, tongue or larynx reported, sometimes after the first dose; discontinue promptly if it occurs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Anticholinergic CNS effects (hallucinations, agitation, confusion, somnolence) may occur; caution in dementia treated with cholinesterase inhibitors, Parkinson's disease, myasthenia gravis, autonomic neuropathy, bladder outflow obstruction, GI obstruction and reflux.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Other anticholinergic drugsMay increase frequency/severity of dry mouth, constipation, somnolence and other anticholinergic effects.DailyMed (U.S. National Library of Medicine)
• Strong CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, erythromycin, clarithromycin)May increase oxybutynin exposure; use caution.DailyMed (U.S. National Library of Medicine)

• Safety in pregnancy not established; animal studies showed no definite harm; give to pregnant women only if probable benefit outweighs possible hazards.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; use caution in nursing women.International label, same formulation · DailyMed (U.S. National Library of Medicine)